Kaddour Chabane

482 total citations
17 papers, 242 citations indexed

About

Kaddour Chabane is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Kaddour Chabane has authored 17 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 12 papers in Hematology and 6 papers in Rheumatology. Recurrent topics in Kaddour Chabane's work include Chronic Lymphocytic Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Eosinophilic Disorders and Syndromes (6 papers). Kaddour Chabane is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Eosinophilic Disorders and Syndromes (6 papers). Kaddour Chabane collaborates with scholars based in France. Kaddour Chabane's co-authors include Sandrine Hayette, Jean‐Pierre Magaud, Mauricette Michallet, Isabelle Tigaud, Sarah Huet, Laurent Jallades, Gilles Salles, Franck E. Nicolini, Pierre Sujobert and Carole Charlot and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Kaddour Chabane

17 papers receiving 241 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaddour Chabane France 10 128 126 86 57 52 17 242
Heather Cazzolli United States 5 270 2.1× 204 1.6× 157 1.8× 50 0.9× 33 0.6× 8 369
Susanna Akiki Qatar 9 219 1.7× 141 1.1× 167 1.9× 38 0.7× 58 1.1× 32 347
Karl Haslam Ireland 8 130 1.0× 142 1.1× 101 1.2× 33 0.6× 87 1.7× 30 267
Yeo‐Kyeoung Kim South Korea 7 119 0.9× 47 0.4× 93 1.1× 54 0.9× 49 0.9× 9 236
Karl-Anton Kreuzer Germany 4 63 0.5× 132 1.0× 54 0.6× 56 1.0× 29 0.6× 5 206
Jiřı́ Schwarz Czechia 11 245 1.9× 249 2.0× 220 2.6× 42 0.7× 64 1.2× 36 403
T. Haferlach Germany 7 197 1.5× 118 0.9× 142 1.7× 57 1.0× 24 0.5× 10 283
Sarah Abu Kar United States 3 241 1.9× 132 1.0× 230 2.7× 38 0.7× 15 0.3× 8 367
Cecilia Arana Yi United States 8 100 0.8× 71 0.6× 80 0.9× 24 0.4× 35 0.7× 21 210
Sabrina Pechtel Germany 9 216 1.7× 81 0.6× 102 1.2× 40 0.7× 14 0.3× 12 292

Countries citing papers authored by Kaddour Chabane

Since Specialization
Citations

This map shows the geographic impact of Kaddour Chabane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaddour Chabane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaddour Chabane more than expected).

Fields of papers citing papers by Kaddour Chabane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaddour Chabane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaddour Chabane. The network helps show where Kaddour Chabane may publish in the future.

Co-authorship network of co-authors of Kaddour Chabane

This figure shows the co-authorship network connecting the top 25 collaborators of Kaddour Chabane. A scholar is included among the top collaborators of Kaddour Chabane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaddour Chabane. Kaddour Chabane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bourbon, Estelle, Kaddour Chabane, Isabelle Mosnier, et al.. (2023). Next-CLL, a New Next-Generation Sequencing–Based Method for Assessment of IGHV Gene Mutational Status in Chronic Lymphoid Leukemia. Journal of Molecular Diagnostics. 25(5). 274–283. 2 indexed citations
2.
Chabane, Kaddour, Carole Charlot, Thomas Simonet, et al.. (2023). Real life evaluation of AlphaMissense predictions in hematological malignancies. Leukemia. 38(2). 420–423. 10 indexed citations
3.
Hayette, Sandrine, Maxime Vallée, Claire Bardel, et al.. (2021). Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological Malignancies. HemaSphere. 5(2). e522–e522. 5 indexed citations
4.
Charrière, Sybil, Thomas Simonet, Véronique Bonnet, et al.. (2018). Single, short in‐del, and copy number variations detection in monogenic dyslipidemia using a next‐generation sequencing strategy. Clinical Genetics. 94(1). 132–140. 15 indexed citations
5.
Lopez, Jonathan, Kaddour Chabane, Sandrine Hayette, et al.. (2018). What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid Malignancies. International Journal of Molecular Sciences. 19(4). 1251–1251. 7 indexed citations
6.
Jallades, Laurent, Lucile Baseggio, Pierre Sujobert, et al.. (2017). Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2 , TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma. Haematologica. 102(10). 1758–1766. 53 indexed citations
7.
Huet, Sarah, Stéphanie Dulucq, Aurélie Chauveau, et al.. (2015). Molecular characterization and follow‐up of five CML patients with new BCR–ABL1 fusion transcripts. Genes Chromosomes and Cancer. 54(10). 595–605. 9 indexed citations
8.
Huet, Sarah, Laurent Jallades, Carole Charlot, et al.. (2013). New Quantitative Method to Identify NPM1 Mutations in Acute Myeloid Leukaemia. PubMed. 2013. 1–5. 5 indexed citations
9.
Hayette, Sandrine, Xavier Thomas, Laurent Jallades, et al.. (2012). High DNA Methyltransferase DNMT3B Levels: A Poor Prognostic Marker in Acute Myeloid Leukemia. PLoS ONE. 7(12). e51527–e51527. 49 indexed citations
10.
11.
12.
Hayette, Sandrine, Kaddour Chabane, Mauricette Michallet, et al.. (2010). Longitudinal studies of SRC family kinases in imatinib- and dasatinib-resistant chronic myelogenous leukemia patients. Leukemia Research. 35(1). 38–43. 15 indexed citations
13.
Nicolini, Franck E., Jean‐Claude Chomel, Lydia Roy, et al.. (2010). The Durable Clearance of the T315I BCR-ABL Mutated Clone in Chronic Phase Chronic Myelogenous Leukemia Patients on Omacetaxine Allows Tyrosine Kinase Inhibitor Rechallenge. Clinical Lymphoma Myeloma & Leukemia. 10(5). 394–399. 27 indexed citations
14.
15.
16.
Nicolini, Franck E., Kaddour Chabane, Isabelle Tigaud, et al.. (2007). BCR-ABL mutant kinetics in CML patients treated with dasatinib. Leukemia Research. 31(6). 865–868. 15 indexed citations
17.
Chabane, Kaddour, Franck E. Nicolini, Jean‐Michel Cayuela, et al.. (2005). The K247R Substitution in ABL Tyrosine Kinase Domain Is Not a Mutation Leading to Imatinib Resistance but a Polymorphism Rarely Present in CML Patients and in Normal Subjects.. Blood. 106(11). 4831–4831. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heather Cazzolli Breakdown of academic impact, for papers by Susanna Akiki Breakdown of academic impact, for papers by Karl Haslam Breakdown of academic impact, for papers by Yeo‐Kyeoung Kim Breakdown of academic impact, for papers by Karl-Anton Kreuzer Breakdown of academic impact, for papers by Jiřı́ Schwarz Breakdown of academic impact, for papers by T. Haferlach Breakdown of academic impact, for papers by Sarah Abu Kar Breakdown of academic impact, for papers by Cecilia Arana Yi Breakdown of academic impact, for papers by Sabrina Pechtel
Rankless by CCL
2026